Moors & Cabot Inc. Sells 13,333 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Moors & Cabot Inc. lowered its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 24.1% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 42,003 shares of the pharmacy operator’s stock after selling 13,333 shares during the quarter. Moors & Cabot Inc.’s holdings in Walgreens Boots Alliance were worth $508,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Iron Horse Wealth Management LLC boosted its stake in Walgreens Boots Alliance by 162.5% in the 2nd quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 1,300 shares during the period. Pineridge Advisors LLC bought a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $26,000. Blue Trust Inc. grew its stake in Walgreens Boots Alliance by 87.0% during the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock valued at $28,000 after acquiring an additional 1,081 shares in the last quarter. Quest Partners LLC purchased a new position in Walgreens Boots Alliance during the fourth quarter valued at approximately $30,000. Finally, Continuum Advisory LLC increased its holdings in Walgreens Boots Alliance by 71.2% during the 2nd quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock worth $30,000 after acquiring an additional 1,020 shares during the period. 58.59% of the stock is currently owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Trading Down 0.3 %

Shares of WBA opened at $8.98 on Friday. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.46 and a fifty-two week high of $27.05. The firm has a market cap of $7.75 billion, a price-to-earnings ratio of -1.33, a PEG ratio of 1.02 and a beta of 0.70. The firm has a 50 day moving average price of $10.35 and a 200-day moving average price of $14.85. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.31 and a current ratio of 0.65.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing the consensus estimate of $0.68 by ($0.05). Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The business had revenue of $36.40 billion during the quarter, compared to the consensus estimate of $35.94 billion. During the same period in the prior year, the firm earned $1.00 earnings per share. The business’s revenue for the quarter was up 2.8% on a year-over-year basis. As a group, equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 2.86 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, September 12th. Investors of record on Wednesday, August 21st were issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 11.14%. The ex-dividend date was Wednesday, August 21st. Walgreens Boots Alliance’s dividend payout ratio is presently -14.84%.

Wall Street Analyst Weigh In

WBA has been the subject of several analyst reports. Barclays cut their price target on shares of Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating for the company in a report on Tuesday, July 23rd. Bank of America dropped their price objective on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research note on Wednesday, September 4th. Morgan Stanley decreased their target price on Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating on the stock in a research note on Friday, June 28th. JPMorgan Chase & Co. dropped their price target on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research report on Friday, August 30th. Finally, Truist Financial cut their price objective on Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating for the company in a report on Friday, June 28th. Four research analysts have rated the stock with a sell rating, ten have given a hold rating and two have assigned a buy rating to the company. According to MarketBeat, Walgreens Boots Alliance presently has a consensus rating of “Hold” and an average price target of $14.73.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.